D. E. Shaw & Co., Inc. - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$10,840,357
+46.5%
282,154
-11.7%
0.01%
+37.5%
Q1 2023$7,401,194
-21.5%
319,706
-11.1%
0.01%
-20.0%
Q4 2022$9,426,367
-0.0%
359,785
-25.0%
0.01%
-9.1%
Q3 2022$9,428,000
+112.6%
479,527
+89.1%
0.01%
+120.0%
Q2 2022$4,435,000
+334.0%
253,582
+306.1%
0.01%
+400.0%
Q1 2022$1,022,000
-51.1%
62,447
-51.3%
0.00%
-50.0%
Q4 2021$2,089,000
+409.5%
128,102
+298.6%
0.00%
Q3 2021$410,000
-27.7%
32,136
-10.1%
0.00%
-100.0%
Q4 2020$567,00035,7360.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders